Skip to main content
. Author manuscript; available in PMC: 2018 Apr 1.
Published in final edited form as: Immunol Lett. 2017 Feb 14;184:7–14. doi: 10.1016/j.imlet.2017.02.006

Fig. 1.

Fig. 1

Effects of IL-17 and/or TNF-α on PD-L1 and PD-L2 mRNA expression in human cancer cell lines HCT116 and LNCaP. (A and B) The cells were treated with IL-17 (20 ng/ml), TNF-α (10 ng/ml), or a combination of both for 3 hours. PD-L1 and PD-L2 mRNA expression was determined by qRT-PCR analysis. Data were represented as means ± SD (error bars) of three independent experiments.